These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6891621)

  • 21. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1.
    Ma RZ; Gao J; Meeker ND; Fillmore PD; Tung KS; Watanabe T; Zachary JF; Offner H; Blankenhorn EP; Teuscher C
    Science; 2002 Jul; 297(5581):620-3. PubMed ID: 12142541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvants, cell-mediated immune responses and autoimmune disease.
    Paterson PY
    J Reticuloendothel Soc; 1973 Nov; 14(5):426-40. PubMed ID: 4762951
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quantitative determination of the paw-swelling activity of pertussis vaccine with special reference to its responsible toxic components.
    Ishida S; Iwasa S; Akama K; Asakawa S; Tai M; Kurokawa M
    Jpn J Med Sci Biol; 1983 Jun; 36(3):157-70. PubMed ID: 6685199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J; Rivera Rivera D; González Pacheco M
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of Bordetella pertussis vaccine on cerebral vascular permeability.
    Amiel SA
    Br J Exp Pathol; 1976 Dec; 57(6):653-62. PubMed ID: 12780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
    Orr B; Douce G; Baillie S; Parton R; Coote J
    Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
    Waxman FJ; Taguiam JM; Whitacre CC
    Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathology of serum-transmitted immune polioencephalomyelitis in C58 mice.
    Homburger H; Abrams GD; Lawton JW; Murphy WJ
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):979-82. PubMed ID: 4765977
    [No Abstract]   [Full Text] [Related]  

  • 31. Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model.
    Mansour M; Brown RG; Morris A; Smith B; Halperin SA
    Clin Vaccine Immunol; 2007 Oct; 14(10):1381-3. PubMed ID: 17715327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse.
    Steffen BJ; Butcher EC; Engelhardt B
    Am J Pathol; 1994 Jul; 145(1):189-201. PubMed ID: 7518194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
    Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
    Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen.
    Munoz JJ; Bernard CC; Mackay IR
    Cell Immunol; 1984 Jan; 83(1):92-100. PubMed ID: 6607126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice.
    Tamura SI; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
    Cell Immunol; 1984 May; 85(2):351-63. PubMed ID: 6609000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of histamine-induced vascular leakage by pertussis toxin in SJL/J mice but not BALB/c mice.
    Yong T; Meininger GA; Linthicum DS
    J Neuroimmunol; 1993 Jun; 45(1-2):47-52. PubMed ID: 8331165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A HYPERACUTE FORM OF ALLERGIC ENCEPHALOMYELITIS.
    LEVINE S; WENK EJ
    Am J Pathol; 1965 Jul; 47(1):61-88. PubMed ID: 14308139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.